سعر سترينجازول 40مجم 21 قرص 2026

Stringazole 40 mg (Serio Pharm-Egypt / Sedico): pantoprazole 40 mg enteric-coated tablets, a proton pump inhibitor for peptic ulcer and acid-related disorders; pack of 21 tablets.

• Short-term (up to 8 weeks) treatment of erosive esophagitis associated with GERDPopulation: Adults and children 5 years and olderDailyMed (U.S. National Library of Medicine)
• Maintenance of healing of erosive esophagitisPopulation: AdultsDailyMed (U.S. National Library of Medicine)
• Pathological hypersecretory conditions including Zollinger-Ellison syndromePopulation: AdultsDailyMed (U.S. National Library of Medicine)

• Serious reactions described in the label include acute tubulointerstitial nephritis, C. difficile-associated diarrhea, bone fracture, severe cutaneous reactions, lupus erythematosus, vitamin B12 deficiency, hypomagnesemia and fundic gland polyps; postmarketing reports include asthenia, fatigue, malaise and pancytopenia.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to any component of the formulation or to any substituted benzimidazole.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Patients receiving rilpivirine-containing products.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Symptomatic response does not exclude gastric malignancy; consider further evaluation if response is suboptimal or symptoms relapse early.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Acute tubulointerstitial nephritis may occur at any time; discontinue if suspected.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Possible increased risk of Clostridioides difficile-associated diarrhea and of osteoporosis-related fractures with high-dose/long-term use; use the lowest dose and shortest duration appropriate.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• RilpivirineContraindicated: PPIs reduce rilpivirine exposure.DailyMed (U.S. National Library of Medicine)
• Methotrexate (high dose)May elevate and prolong methotrexate levels; temporary PPI withdrawal may be considered.DailyMed (U.S. National Library of Medicine)

• Published observational data did not show an association of pantoprazole with major malformations or other adverse pregnancy outcomes; animal reproduction studies showed no adverse developmental outcomes.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Pantoprazole is detected at low levels in breast milk after a 40 mg dose, with no effects on the breastfed infant reported; weigh benefits of breastfeeding against maternal need.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Pantoprazole: Suppresses the final step of gastric acid production by covalently binding to the (H+,K+)-ATPase of the gastric parietal cell; antisecretory effect lasts longer than 24 hours.